Digestives & Intestinal Remedies - Bulgaria

  • Bulgaria
  • In Bulgaria, the Digestives & Intestinal Remedies market market generated a revenue of US$64.42m in 2024.
  • It is projected to experience an annual growth rate of 3.97% (CAGR 2024-2029).
  • Comparatively, in China leads the global market with a revenue of US$4,408.00m in 2024.
  • When considering the population, per person revenues in Bulgaria amount to US$9.73 in 2024.
  • The Digestives & Intestinal Remedies market in Bulgaria is witnessing a surge in demand due to the increasing prevalence of digestive disorders among the population.

Key regions: Canada, United States, Australia, Brazil, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Bulgaria has been experiencing steady growth in recent years, driven by changing customer preferences and local special circumstances.

Customer preferences:
In Bulgaria, there is a growing awareness and interest in digestive health and overall well-being. Consumers are becoming more conscious of the importance of maintaining a healthy digestive system and are actively seeking products that can help improve their digestive health. This has led to an increased demand for Digestives & Intestinal Remedies in the market.

Trends in the market:
One of the key trends in the Digestives & Intestinal Remedies market in Bulgaria is the shift towards natural and herbal remedies. Consumers are increasingly looking for products that are made from natural ingredients and have fewer side effects. This trend is driven by a desire for more holistic and sustainable approaches to health and wellness. As a result, there has been a rise in the popularity of herbal remedies and traditional medicines in the market.Another trend in the market is the growing popularity of probiotics. Probiotics are live bacteria and yeasts that are good for your health, especially your digestive system. They are found in various food products such as yogurt, kefir, and sauerkraut, as well as in supplement form. The demand for probiotics has been increasing as consumers recognize the benefits of these live microorganisms in promoting a healthy gut.

Local special circumstances:
Bulgaria has a rich history and tradition of herbal medicine. The country is known for its diverse flora and has a long-standing tradition of using herbs for medicinal purposes. This cultural heritage has influenced consumer preferences in the Digestives & Intestinal Remedies market, with many consumers opting for herbal remedies that have been used for generations.Additionally, the relatively low cost of Digestives & Intestinal Remedies in Bulgaria compared to other European countries has made them more accessible to a wider range of consumers. This affordability factor has contributed to the growth of the market, as consumers are more inclined to purchase these products.

Underlying macroeconomic factors:
The growing demand for Digestives & Intestinal Remedies in Bulgaria can also be attributed to underlying macroeconomic factors. The country has been experiencing steady economic growth, which has resulted in an increase in disposable income. As a result, consumers have more purchasing power and are willing to spend on products that can improve their health and well-being.Furthermore, the aging population in Bulgaria has also contributed to the growth of the Digestives & Intestinal Remedies market. As people age, they are more prone to digestive issues and are more likely to seek remedies to alleviate their symptoms. This demographic trend has created a larger consumer base for Digestives & Intestinal Remedies in the country.In conclusion, the Digestives & Intestinal Remedies market in Bulgaria is developing due to changing customer preferences towards natural and herbal remedies, the growing popularity of probiotics, the country's rich tradition of herbal medicine, the affordability of these products, and underlying macroeconomic factors such as steady economic growth and an aging population.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)